CD26 is a potential therapeutic target by humanized monoclonal antibody for the treatment of multiple myeloma

CD26 is a potential therapeutic target by humanized monoclonal antibody for the treatment of multiple myelomaCD26 is a potential therapeutic target by humanized monoclonal antibody for the treatment of multiple myeloma, Published online: 22 October 2018; doi:10.1038/s41408-018-0127-yCD26 is a potential therapeutic target by humanized monoclonal antibody for the treatment of multiple myeloma

Source: Blood Cancer Journal - October 22, 2018 Category: Hematology Authors: Hiroko Nishida Mutsumi Hayashi Chikao Morimoto Michiie Sakamoto Taketo Yamada Source Type: research